At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TIL Instil Bio, Inc.
Post-Market Trading 10-23 18:25:47 EDT
31.81
-1.77
-5.27%
盘后31.89
+0.08+0.25%
17:54 EDT
High34.24
Low31.68
Vol59.86K
Open33.58
D1 Closing33.58
Amplitude7.62%
Mkt Cap206.89M
Tradable Cap73.21M
Total Shares6.50M
T/O1.95M
T/O Rate2.60%
Tradable Shares2.30M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Summit Stock Skyrockets Nearly 700% YTD: Time to Sell or Hold?
Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research
Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need.
Instil Bio has research and cell therapy manufacturing facilities in Los Angeles, CA and Manchester, UK, with corporate offices in Dallas, TX.